Related Experiment Videos

Glucagon-like peptide-1(7-36) amide is a new incretin/enterogastrone candidate

R Göke¹, H C Fehmann, B Göke

¹Department of Internal Medicine, Philipps University of Marburg, Germany.

European Journal of Clinical Investigation

|April 1, 1991

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Characteristics of high- and low-risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in Type 2 diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2018

Efficacy of vildagliptin and sitagliptin in lowering fasting plasma glucose: Results of a randomized controlled trial.

Diabetes & metabolism·2014

Real-life efficacy and safety of vildagliptin compared with sulfonylureas as add-on to metformin in patients with type 2 diabetes mellitus in Germany.

Current medical research and opinion·2013

[Diseases in gastroenterology].

Der Internist·2013

Effectiveness and tolerability of second-line therapy with vildagliptin vs. other oral agents in type 2 diabetes: a real-life worldwide observational study (EDGE).

International journal of clinical practice·2013

Sodium iodide symporter (NIS)-mediated radiovirotherapy of hepatocellular cancer using a conditionally replicating adenovirus.

Gene therapy·2012

See all related articles